retatrutide type 2 diabetes trial results 2024 2025 – The New Weight Loss Helper Retatrutide is a new medication being developed by Eli Lilly to help people lose weight. It's like a super version of drugs such as Ozempic Triple hormone receptor agonist retatrutide

The common side effects are nausea, reflux, diarrhoea, constipation, reduced appetite, and fatigue

While injectables and oral medications havent been compared in a head-to-head study, the injectable forms of the drug may be more effective for weight loss because they contribute to higher blood levels of the medication, Kushner says

Many women will benefit from higher targets depending on body size and goals

The views and opinions expressed in this article are those of the author and do not necessarily reflect the views or positions of the Novo Nordisk Foundation

Veiseh and our team today by calling our office or scheduling a visit online.